share_log

Argus Research Maintains Buy on United Therapeutics, Lowers Price Target to $280

Argus Research Maintains Buy on United Therapeutics, Lowers Price Target to $280

阿格斯研究维持对United Therapeutics的买入,将目标价下调至280美元
Benzinga ·  2023/04/21 09:23

Argus Research analyst Jasper Hellweg maintains United Therapeutics (NASDAQ:UTHR) with a Buy and lowers the price target from $300 to $280.

阿格斯研究分析师贾斯珀·赫尔维格维持United Therapeutics(纳斯达克股票代码:UTHR)的买入,并将目标股价从300美元下调至280美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发